GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » Medicale Corp (OTCPK:MCLE) » Definitions » EBITDA Margin %

MCLE (Medicale) EBITDA Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medicale EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medicale's EBITDA for the three months ended in Jun. 2024 was $-0.01 Mil. Medicale's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Medicale's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.


Medicale EBITDA Margin % Historical Data

The historical data trend for Medicale's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicale EBITDA Margin % Chart

Medicale Annual Data
Trend Sep20 Sep21 Sep22 Sep23
EBITDA Margin %
- - - -

Medicale Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medicale's EBITDA Margin %

For the Food Distribution subindustry, Medicale's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicale's EBITDA Margin % Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, Medicale's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medicale's EBITDA Margin % falls into.



Medicale EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medicale's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-0.038/0
= %

Medicale's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.009/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicale  (OTCPK:MCLE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Medicale EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Medicale's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicale Business Description

Traded in Other Exchanges
N/A
Address
9314 Forest Hill boulevard, No. 929, Wellington, FL, USA, 33411
Medicale Corp is plans to offer consulting services and distribution of dietary supplements. A dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. A supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, in order to increase the quantity of their consumption.

Medicale Headlines

No Headlines